BPG is committed to discovery and dissemination of knowledge
Basic Study
©The Author(s) 2026.
World J Gastrointest Oncol. Feb 15, 2026; 18(2): 114161
Published online Feb 15, 2026. doi: 10.4251/wjgo.v18.i2.114161
Table 2 Summary of molecular marker expression changes in patient-derived gastric intestinal metaplasia organoids after taurine intervention
Patient
Marker
Normal untreated
Normal + taurine (vs untreated normal)
GIM untreated (vs untreated normal)
GIM + taurine (vs untreated GIM)
P value (GIM + taurine vs untreated GIM)
Detection method
All (1-3)CDX2Baseline-Upregulated (significant)Downregulated (significant)< 0.05qPCR, WB
All (1-3)MUC2Baseline-Upregulated (significant)Downregulated (significant)< 0.05qPCR
All (1-3)TFF3Baseline-Upregulated (significant)Downregulated (significant)< 0.05qPCR, WB
1 & 3MUC5ACBaseline-Downregulated (significant)Upregulated (significant)< 0.05qPCR
2MUC5ACBaseline-Downregulated (significant)Upregulated (nonsignificant)> 0.05qPCR


Write to the Help Desk